Hyzaar Forte

Losartan potassium and hydrochlorothiazide, the active ingredients in Hyzaar Forte, are an angiotensin II receptor blocker and a thiazide diuretic presented as oral tablets for systemic use. They treat hypertension in adult patients. The combination provides complementary blood‑pressure control by blocking vasoconstriction and promoting sodium excretion.

GNH USA supplies Hyzaar Forte as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to stringent quality standards and providing reliable logistics for global distribution. Our network ensures timely delivery and regulatory compliance across EU and other markets.

Hyzaar Forte is used to manage hypertension, a condition characterized by elevated arterial pressure.

- Hypertension: lowers elevated blood pressure in adults, helping reduce cardiovascular risk. - Hypertension with diabetes: improves blood‑pressure control in patients who also have type 2 diabetes. - Hypertension with chronic kidney disease: assists in managing blood pressure in patients with renal impairment.

Hyzaar Forte may be associated with a range of adverse reactions, varying in frequency and severity.

Common Side Effects: - Dizziness - Headache - Increased urination

Serious or Rare Side Effects: - Severe dehydration - Acute kidney injury - Hyperkalemia

When prescribing Hyzaar Forte, clinicians should consider several precautionary measures to ensure safe use.

- Renal function: assess kidney function before initiation and monitor periodically. - Electrolytes: monitor serum potassium and sodium levels during therapy. - Volume depletion: avoid use in patients with significant dehydration or diuretic overuse. - Concomitant NSAIDs: use caution as they may reduce antihypertensive effect and increase renal risk. - Pregnancy: avoid use during pregnancy due to potential fetal toxicity. - Store at ambient temperature: keep tablets below 25 °C in the original container, protected from moisture.

Hyzaar Forte can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Potassium‑sparing diuretics or supplements: may cause hyperkalemia. - ACE inhibitors or other ARBs: increased risk of renal impairment and hyperkalemia. - Lithium: may increase lithium levels leading to toxicity.

Moderate Interactions (Monitor Closely): - NSAIDs: can diminish antihypertensive effect and affect renal function. - Antidiabetic drugs: may enhance hypoglycemic effect. - CYP2C9 inhibitors (e.g., fluconazole): may increase losartan levels.